閾剁墝浼氬憳绗?span style="font-size:1.5em;color:#f21">2骞滁/div> 璁块棶閲廁 3610679 缃戝潃:antibody.cnreagent.com 鍦ㄧ嚎鐣欒█
浜у搧鎼滅储
鎶椾綋 >> 鍏朵粬鎶椾綋
鑳炶啘闂村唴璐ㄧ綉璋冭妭铔嬬櫧1鎶椾綋
鑳炶啘闂村唴璐ㄧ綉璋冭妭铔嬬櫧1鎶椾綋鍥剧墖
浜よ揣鏈烔 1鍛?/span>
绱㈠彇璧勬枡鍙婃姤浠饵/span>
浜よ揣鏈烔 1鍛?/td>
浜у搧鍒悕: Anti-Rint1
Anti-RAD50 interactor 1 Antibody
浜у搧浠嬬粛
闈舵爣锛欬p style="text-indent: 2em;">Rint1


浜у搧鍒悕锛欬p style="text-indent: 2em;">CG8605锛 Dmel\CG8605锛 Rint-1锛 Tip20锛 rint1锛 Rint1锛 RAD50 interactor 1锛 RAD50 interactor 1锛 RAD50 interactor 1锛 CG8605-PA锛 RINT1 ortholog锛 Rint1-PA锛 鑳炶啘闂村唴璐ㄧ綉璋冭妭铔嬬櫧1锛


鑳屾櫙淇℃伅锛欬div style="text-indent: 2em;">developmental stage:Expressed throughout the cell cycle.,function:Involved in regulation of membrane traffic between the Golgi and the endoplasmic reticulum. May play a role in cell cycle checkpoint control. Essential for telomere length control.,miscellaneous:According to PubMed:11096100, a longer form, which may be due to the differential initiation of translation using a non-AUG codon, may exist. However, the existence of such form has not been clearly demonstrated.,similarity:Belongs to the RINT1 family.,similarity:Contains 1 RINT1/TIP20 domain.,subunit:Associated with a SNARE complex consisting of STX18, USE1L, BNIP1/SEC20L, and SEC22B. Interacts directly with BNIP1/SEC20L and ZW10. Interacts with RAD50 during late S and G2/M phases. Interacts with RBL2, preferentially with the active, hypophosphorylated form.,

瀹夸富锛歊bt
绫诲瀷锛歅ab
鍚岀鍨婜IgG
搴旂敤锛歐B
绾寲鏂瑰紡锛氫翰鍜岀函鍖朁br/>鍋惰仈鐗╋細Unconjugated
鎬х姸锛氭恫浣
瀛樺偍婧舵恫锛氬弬闃呰鏄庝功
娴撳害锛欱atch dependent (Please refer to the vial label for the specific concentration.)
绋€閲婃瘮渚婜 Optimal dilutions/concentrations should be determined by the end user
鍌ㄥ瓨锛氱粡甯镐娇鐢ㄥ垯4掳C淇濆瓨銆?20掳C淇濆瓨涓嶈秴杩囦袱骞淬€傞伩鍏嶅弽澶嶅喕铻嶃€侟br/>娉ㄦ剰浜嬮」锛氫粎渚涘疄楠屽浣跨敤銆備笉閫傜敤浜庝汉绫绘垨鍔ㄧ墿鐨勪换浣曚复搴婏紝娌荤枟鎴栬瘖鏂敤閫斻€備笉閫傚悎鍔ㄧ墿鎴栦汉绫婚鐢ㄣ€侟/p>

鐩稿叧浜у搧
Baidu
map